Analysts say the acquisition positions ClickHouse to help enterprises run AI more reliably and transparently by pairing high‑performance analytics with native LLM observability tools. ClickHouse has ...

The Agriculture Department received overwhelmingly negative feedback on its plan to relocate thousands of staff and consolidate dozens of offices, as employees, lawmakers and stakeholders said it ...

I was recently reading an article 1 on the science of kindness that emphasized how acts of kindness (doing them and witnessing them) produce measurable neurochemical and physiological effects. Being ...

Kristin Cavallari is preaching the practice of “self-talk” after struggling with her own negative thoughts regarding body image. “I know for me personally, growing up I always had a really negative ...

Editor's Note: This is an excerpt of WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. When my mental health is in shambles, I often ...

Millions of Americans have thyroid disorders, but up to 60 percent don’t know it. From subtle tremors to creeping brain fog, here’s what doctors say you shouldn’t ignore. A woman with an enlarged ...

Forbes contributors publish independent expert analyses and insights. Lucy Paulise is executive coach and author of Timebox, based in Texas. Even when you’re hitting your goals, negative feedback can ...

The top US regulator of medicines this week said he wants to officially approve an animal-derived thyroid drug, seemingly addressing concerns sparked by a press release from his own agency. On August ...

Thyroid hormones—primarily T3 (triiodothyronine) and T4 (thyroxine)—are essential for regulating numerous physiological processes, including development, metabolism and energy production. Diet plays a ...

PREGNANCY imposes significant metabolic and endocrine demands, making conditions like gestational thyroid dysfunction and gestational diabetes particularly common and sometimes overlapping. Although ...

Pyrotinib in the first-line treatment of HER2-positive advanced breast cancer: Results from the PRETTY study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...